BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $112 at Barclays
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $91.20 -0.93%
Rating Summary:
23 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 2
Rating Summary:
23 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 2
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $112.00 (from $114.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Increasing unusual put option volume: BMRN BKR JBLU HCP FTAI IP EDU BSX
- UBS Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
- Increasing unusual option volume: BKR NSC CYH FTAI SGMO BMRN LDOS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
